A Cross Sectional Study on Correlation of Quantitative C - reactive protein with CD4 Count in Patients of HIV on Art
DOI:
https://doi.org/10.48165/e9dssv11Keywords:
HIV, CRP, CD 4, HAARTAbstract
Background: Over the past two decades with the advent of highly active antiretroviral therapy (HAART), there is a substantial increase in the life span of HIV patients. Hence, the focus has now shifted to managing long-term complications of HIV infection and improving the quality of life of HIV patients, especially in developed nations. On the other hand, in developing nations, the ever-growing incidence of HIV infection has placed a huge burden on their frail economy, so there is a growing need for simplifying HIV treatment protocols and for having cheaper alternatives for monitoring disease activity. Subjects and Methods: The present study was a cross sectional hospital based study for a period of twelve months from 1st Nov. 2015 to 31st Oct. 2016 at ART center P.B.M. Hospital, Bikaner. 100 HIV+ patients on ART were included in the study by consecutive sampling technique. Out of 100 patients, 50 were symptomatic and included in study group and remaining 50 were asymptomatic and taken as controls. Results: 37 (74%) patients in study group had CRP levels >6 mg/lit (normal level <6 mg/lit). Out of 37, 19 subjects (38% of total) had CRP level >20 mg/lit. While in control group, 44 subjects (88%) had CRP level <6 mg/lit. Only 6 (12%) subjects of control group had CRP level >6mg/lit. None of control subjects had CRP level >20 mg/lit. The CRP levels and CD4 count were negatively correlated in study group and this was observed to be statistically significant (p=0.04) whereas in control group, the CRP levels and CD4 counts were found to be very weakly positively correlated and this correlation was observed to be statistically insignificant. Conclusion: There was statistical significant difference between CRP range and levels in both the groups. Also statistical significant difference between CD4 count range in both the groups. In our study, 38% of the study group patients had CRP >20 mg/l whereas 88% of the control subjects had CRP of <6 mg/l.
References
1. Joint United Nations Program on HIV/AIDS. 14 January 2007 accession date. AIDS epidemic update: December 2005. http://www.unaids.org/epi/2005.
2. Lau, B., A. R. Sharrett, L. A. Kingsley, W. Post, F. J. Palella, B. Visscher, and S. J. Gange. 2006. C-reactive protein is a marker for human immunodeficiency virus disease progression. Arch. Intern. Med. 166:64-70.
3. Achhra AC, Petoumenos K, Law MG. Relationship between CD4 cell count and serious long-term complications among HIV-positive individuals. Curr Opin HIV AIDS 2014; 9: 63–71.
4. Melchior JC, Niyongabo T, Henzel D, Durack-Bown I, Henri SC, Boulier A. Malnutrition and wasting, immunodepression, and chronic inflammation as independent predictors of survival in HIV-infected patients. Nutrition 1999, Nov-Dec;15(11-12):865-9.
5. Szalai AJ, Agrawal A, Greenhough TJ, Volanakis JE. C-reactive protein: structural biology and host defense function. ClinChem Lab Med. 1999;37(3):265-270.
6. Dong Q, Wright JR. Expression of C-reactive protein by alveolar macrophages. J Immunol 1996;156(12):4815-4820.
7. Bentwich Z, Kalinkovich A, Weisman Z. Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol Today 1995;16:187-91. [PUBMED]
8. Rizzardini G, Piconi S, Ruzzante S, Fusi ML, Lukwiya M, Declich S, et al. Immunological activation markers in the serum of African and European HIV-seropositive and seronegative individuals. AIDS 1996;10:1535-42 [PUBMED]
9. McCune JM. The dynamics of CD4+T-cell depletion in HIV disease. Nature 2001;410:974-9. [PUBMED]
10. Douek DC. Disrupting T-cell homeostasis: How HIV-1 infection causes disease. AIDS Rev 2003;5:172-7. [PUBMED]
11. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006;12:1365-71. [PUBMED]
12. Brenchley JM, Price DA, Douek DC. HIV disease: Fallout from a mucosal catastrophe? Nat Immunol 2006;7:235-9 [PUBMED] 13. Zulu I, Hassan G, Njobvu RN, Dhaliwal W, Sianongo S, Kelly P.
Cytokine activation is predictive of mortality in Zambian patients with AIDS-related diarrhoea. BMC Infect Dis 2008;8:156. [PUBMED] 14. Schleicher, G. K., V. Herbert, A. Brink, S. Martin, R. Maraj, J. S. Galpin, and C. Feldman. 2005. Procalcitonin and C-reactive protein levels in HIV-positive subjects with tuberculosis and pneumonia. Eur. Respir. J. 25:688-692.
15. Monica Chaudhary, Bineeta Kashyap, Hitender Gautam, Sanjeev Saini, and Preena Bhalla. Viral Immunology. June 2008, 21(2): 263- 266. doi:10.1089/vim.2007.0083.
16. Ugwu MC. Human serum protein and C-Reactive Protein levels among HIV infected subjects in uromi and its environs in Edo, Nigeria. IJBAIR, 2016, 5(3): 74-80.
17. Reingold JS et al. The Fat Redistribution and Metabolic Change in HIV Infection (FRAM) Study J Acquir Immune Defic Syndr. 2008 Jun 1; 48(2): 142–148.
18. Vishwanath A, Quaiser S, Khan R. Role of high-sensitivity C-reactive protein measurements in HIV patients. Indian J Sex Transm Dis [serial online] 2016 [cited 2016 Dec 30];37:123-8. Available from: http://www.ijstd.org/text.asp?2016/37/2/123/192127
19. Redd AD, Eaton KP, Kong X, et al. C-reactive protein levels increase during HIV-1 disease progression in Rakai, Uganda despite the absence of microbial translocation. Journal of acquired immune deficiency syndromes (1999). 2010;54(5):556-559. doi:10.1097/QAI.0b013 e3181e0cdea.
20. Drain PK, Kupka R, Msamanga GI, Urassa W, Mugusi F, Fawzi WW. C-reactive protein independently predicts HIV-related outcomes among women and children in a resource-poor setting. AIDS 2007; 21:2067-75.
21. S Bhagyabati Devi, Robinson Ningshen, Arvind G. Burden of Opportunistic Infections in HIV/AIDS Patients in the Highly Active Antiretroviral Therapy Era: A Regional Institute of Medical Sciences, Imphal Perspective; http://www.apiindia.org/medicine _update _2013/chap15.pdf
22. Tahir A, Yusuph H, Bakki B and Jibrin YB (2013). Correlation between c-reactive protein and CD4+ cell count in HIV-infected and HIV/PTB co-infected patients at the university of maiduguri teaching hospital (UMTH), Maiduguri, Nigeria. Front. Immunol. Conference Abstract: 15th International Congress of Immunology (ICI). doi: 10.338
23. Skogmar S, Schön T, Balcha TT, Sturegård E, Jansson M, Björkman P (2015) Plasma Levels of Neopterin and C-Reactive Protein (CRP) in Tuberculosis (TB) with and without HIV Coinfection in Relation to CD4 Cell Count. PLoS ONE 10(12): e0144292.
24. S. D. Lawn, A. D. Kerkhoff, M. Vogt, R. Wood. Diagnostic and prognostic value of serum C-reactive protein for screening for HIV associated tuberculosis. INT J TUBERC LUNG DIS 2013 17(5):636– 643.
